Table 1.
Clinical and endocrine characteristics of control women (CE) and women with PCOS with (PCOSE-HI) or without hyperinsulinemia (PCOSE-NI).
| Parameters | CE | PCOSE-NI | PCOSE-HI |
|---|---|---|---|
| Age, y | 39.3 ± 1.8 | 25.2 ± 1.1 | 28.4 ± 0.9 |
| Body mass index | 26 ± 2.3 | 28.7 ± 2.1 | 33.9 ± 1.1a |
| Estradiol, pg/mL | 73.8 ± 22.4 | 63.4 ± 7.9 | 59 ± 4.2 |
| Progesterone, ng/mL | 0.6 ± 0.2 | 0.6 ± 0.1 | 0.5 ± 0.1 |
| Androstenedione, ng/mL | 1.6 ± 0.4 | 3.1 ± 0.4a | 2.5 ± 0.7 |
| Testosterone, ng/mL | 0.3 ± 0.1 | 0.8 ± 0.1a | 0.8 ± 0.1a |
| SHBG, nmol/mL | 51.7 ± 9.5 | 25.8 ± 2.3 | 22.8 ± 4.1 |
| Free-androgen index | 3.1 ± 1.1 | 10.3 ± 2.0a | 10.7 ± 2.0a |
a
P < 0.05 compared with CE.